The drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to an article to be published Wednesday in a leading medical journal.
The article, based on documents unearthed in lawsuits over the pain drug Vioxx, provides a rare, detailed look in the industry practice of ghostwriting medical research studies that are then published in academic journals.
Merck Wrote Drug Studies For Doctors
Tela Love, a 36-year-old transgender woman who used to work the streets of New Orleans’ French...
The Food and Drug Administration will issue two major proposals Wednesday in an effort to cut...
